• Technology
  • DuplexSeq™ Kits
    • AML Assay
    • Mutagenesis Assay
    • Custom
  • Resources
    • Publications
    • Posters
    • Safety
    • Patents
  • Company
    • Our Team
    • Careers
    • Events
    • News
    • Investors
  • Contact

On-demand webinar

The future of mutagenesis testing is here.

Watch now
TwinStrand Biosciences
  • Technology
  • DuplexSeq™ Kits
    • AML Assay
    • Mutagenesis Assay
    • Custom
  • Resources
    • Publications
    • Posters
    • Safety
    • Patents
  • Company
    • Our Team
    • Careers
    • Events
    • News
    • Investors
  • Contact

 

TwinStrand DuplexSeqTM assays can help you identify AML-related mutations with 100-fold higher resolution than standard NGS

 

Want to learn more about how our duplex sequencing can advance your AML MRD research?

The TwinStrand DuplexSeqTM AML-29 MRD assay leverages duplex sequencing technology for high sensitivity detection of ultra-low frequency mutations across 29 genes associated with adult acute myeloid leukemia (AML).
 
Our Data Sheet details the performance specifications for our DuplexSeq assay that enables consistent sub-1/10,000 variant allele frequency detection.


 

We Hope You Enjoyed ASH 2022!

 

 

Interested in bringing TwinStrand DuplexSeqTM assays into your lab?

 

Learn more about our AML panel covering 29 genes recurrently mutated in Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), & Clonal Hematopoiesis (CHIP)

 

Learn More

 

Contact us to discuss our custom panel services

 

Contact Us

 

Use CODE “ASH2022” to take advantage of our BOGO 50% kit promotion through January 31, 2023

 

TwinStrand Biosciences, Inc.
3131 Elliott Ave, Suite 750 • Seattle, WA 98121 • USA
+1 (877) 202-TWIN

 

For Research Use Only. Not for use in diagnostic procedures.

©2022 TwinStrand Biosciences, Inc. All rights reserved. All trademarks are the property of TwinStrand Biosciences, Inc. or their respective owners.  Legal Notices

  




American Society of Hematology (ASH)

December 5-8, 2020 – Virtual

 

Poster Presentation

 

“Duplex Sequencing with Patient-Specific Hybrid Capture Panels Reveals Ultra-Low Frequency Measurable Residual Disease in Pediatric Acute Myeloid Leukemia”

 

Presented by Jake Higgins, Senior Scientist – December 6, 2020 7:00 a.m.-3:30 p.m. PST

 

Conference Website

 

Society of Toxicology (SOT)

March 10-14, 2019 – Baltimore, MD

 

Poster Presentations

 

 

View Poster

 

 

Conference Website

 

AACR Annual Meeting – San Diego, CA

March 29-April 3, 2019

 

Poster Presentations

 

 

View Poster

 

 

View Poster

Presentations by CEO Jesse Salk, MD, PhD – AGBT 2020

Ultra-Sensitive Residual Leukemia Detection with Patient-Specific Dupex Sequencing